Ameriprise’s Evolv Technologies EVLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$294K Sell
48,656
-26,551
-35% -$155K ﹤0.01% 3764
2025
Q4
$538K Sell
75,207
-33,525
-31% -$238K ﹤0.01% 3596
2025
Q3
$821K Buy
+108,732
New +$794K ﹤0.01% 3448
2025
Q2
Sell
-18,275
Closed -$57K 4010
2025
Q1
$57K Sell
18,275
-343
-2% -$1.2K ﹤0.01% 3935
2024
Q4
$73.5K Buy
+18,618
New +$65.3K ﹤0.01% 3981

Other funds holding EVLV

Ameriprise's EVLV Position: Q1 2026 in Review

Ameriprise reduced its Evolv Technologies (EVLV) stake by 35% in Q1 2026, selling an estimated $155K and leaving 48,656 shares worth $294K. The position accounts for ﹤0.01% of the portfolio, ranked #3764.

Ameriprise first reported a position in EVLV in Q4 2024 and has held it in 5 quarters since. The position peaked at $821K in Q3 2025. 260 funds tracked by Wall St. Rank hold EVLV as of Q1 2026.

  • Ameriprise held 48,656 shares of Evolv Technologies worth $294K as of Q1 2026.
  • Ameriprise sold 26,551 Evolv Technologies shares in Q1 2026, an estimated $155K.
  • Evolv Technologies made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3764 holding.
  • Ameriprise first reported a position in Evolv Technologies in Q4 2024 and has held it in 5 quarters since.
  • Ameriprise's Evolv Technologies position peaked at $821K in Q3 2025.
  • 260 funds tracked by Wall St. Rank held Evolv Technologies as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.